Merck’s Keytruda could offer ‘paradigm shift’ in lung cancer treatment 

Thursday, July 5, 2018 - 18:22 in Health & Medicine

Results from a large Phase III study of the cancer immunotherapy were reported at cancer conference

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net